Thomas Catinazzo Relay Therapeutics, Inc. (RLAY) insider trading activity

RLAY Quotes by TradingView

Thomas Catinazzo is Chief Financial Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 313,631 shares of RLAY, which is worth approximately $2.08 Million. The most recent transaction as insider was on Jun 07, 2021, when has been sold 22,500 shares (Common Stock) at a price of $4.12 per share, resulting in proceeds of $92,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 314K
6.46% 3M change
4.81% 12M change
Total Value Held $2.08 Million

Thomas Catinazzo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 36.96%
38,370 Common Stock
Mar 30 2021
SELL
Open market or private sale
$787,500 $35.0 p/Share
22,500 Reduced 100.0%
0 Common Stock
Mar 30 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 50.0%
22,500 Common Stock
Mar 26 2021
BUY
Grant, award, or other acquisition
-
15,870 Added 50.0%
15,870 Common Stock
TC

Thomas Catinazzo

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on RLAY

Follow Relay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

News

Receive news related to Relay Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLAY